Pharma Resources (Shanghai) Co (SZSE:301230) 3-Year EBITDA Growth Rate : -5.70% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Pharma Resources (Shanghai) Co 3-Year EBITDA Growth Rate?

Pharma Resources (Shanghai) Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.03.

During the past 12 months, Pharma Resources (Shanghai) Co's average EBITDA Per Share Growth Rate was -70.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -5.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pharma Resources (Shanghai) Co was 72.00% per year. The lowest was -5.70% per year. And the median was 29.20% per year.

Competitive Comparison of Pharma Resources (Shanghai) Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Pharma Resources (Shanghai) Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Resources (Shanghai) Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Resources (Shanghai) Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pharma Resources (Shanghai) Co's 3-Year EBITDA Growth Rate falls into.

Pharma Resources (Shanghai) Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Pharma Resources (Shanghai) Co (SZSE:301230) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Pharma Resources (Shanghai) Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Pharma Resources (Shanghai) Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Resources (Shanghai) Co (SZSE:301230) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Resources (Shanghai) Co Ltd (SZSE:301230) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 315, Qingda Road, Building 23, Pudong New Area, Shanghai, CHN, 201201

Website

http://www.pharmaresources.cn

Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research and development of pharmaceutical processes, and commercial production of API intermediates.

Pharma Resources (Shanghai) Co (SZSE:301230) Headlines

No Headlines